R01 CA135358/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	1
2010	2
2011	3
2012	2
2013	1
2017	1
2020	1
2022	1
2024	0

1

Image-guided nanosystems for targeted delivery in cancer therapy.

Iyer AK, He J, Amiji MM. Iyer AK, et al. Curr Med Chem. 2012;19(19):3230-40. doi: 10.2174/092986712800784685. Curr Med Chem. 2012. PMID: 22612697 Free PMC article. Review.

2

Molecular Radiotherapy with ¹⁷⁷Lu-Immunoliposomes Induces Cytotoxicity in Mesothelioma Cancer Stem Cells In Vitro.

Huang T, Lee JS, Klibanov AL, He J. Huang T, et al. Int J Mol Sci. 2022 Apr 1;23(7):3914. doi: 10.3390/ijms23073914. Int J Mol Sci. 2022. PMID: 35409274 Free PMC article.

3

Quantitative ^99mTc Labeling Kit for HYNIC-Conjugated Single Chain Antibody Fragments Targeting Malignant Mesothelioma.

He J, Feng J, Su Y, Seo Y, Liu B. He J, et al. Bioconjug Chem. 2020 Jul 15;31(7):1750-1755. doi: 10.1021/acs.bioconjchem.0c00319. Epub 2020 Jul 6. Bioconjug Chem. 2020. PMID: 32628464 Free PMC article.

4

Radiolabeled oligonucleotides for antisense imaging.

Iyer AK, He J. Iyer AK, et al. Curr Org Synth. 2011 Aug 1;8(4):604-614. doi: 10.2174/157017911796117241. Curr Org Synth. 2011. PMID: 21822406 Free PMC article.

5

Preclinical SPECT and SPECT/CT.

Seo Y, Jiang H, Franc BL. Seo Y, et al. Recent Results Cancer Res. 2013;187:193-220. doi: 10.1007/978-3-642-10853-2_6. Recent Results Cancer Res. 2013. PMID: 23179882 Review.

6

Initial evaluation of Cu-64 labeled PARPi-DOTA PET imaging in mice with mesothelioma.

Huang T, Hu P, Banizs AB, He J. Huang T, et al. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3472-3476. doi: 10.1016/j.bmcl.2017.05.077. Epub 2017 May 26. Bioorg Med Chem Lett. 2017. PMID: 28587822 Free PMC article.

7

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ. Christine CW, et al. Neurology. 2009 Nov 17;73(20):1662-9. doi: 10.1212/WNL.0b013e3181c29356. Epub 2009 Oct 14. Neurology. 2009. PMID: 19828868 Free PMC article. Clinical Trial.

8

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.

He J, Wang Y, Dou S, Liu X, Zhang S, Liu G, Hnatowich D. He J, et al. Mol Pharm. 2010 Aug 2;7(4):1118-24. doi: 10.1021/mp9002909. Mol Pharm. 2010. PMID: 20507096 Free PMC article.

9

Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment.

He J, Wang Y, Feng J, Zhu X, Lan X, Iyer AK, Zhang N, Seo Y, VanBrocklin HF, Liu B. He J, et al. J Nucl Med. 2010 Mar;51(3):427-32. doi: 10.2967/jnumed.109.069492. Epub 2010 Feb 11. J Nucl Med. 2010. PMID: 20150269 Free PMC article.

10

Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas.

Iyer AK, Lan X, Zhu X, Su Y, Feng J, Zhang X, Gao D, Seo Y, Vanbrocklin HF, Broaddus VC, Liu B, He J. Iyer AK, et al. Cancer Res. 2011 Apr 1;71(7):2428-32. doi: 10.1158/0008-5472.CAN-10-3484. Epub 2011 Mar 29. Cancer Res. 2011. PMID: 21447742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year